RedHill Biopharma (RDHL) Assets Average: 2012-2024
Historic Assets Average for RedHill Biopharma (RDHL) over the last 13 years, with Dec 2024 value amounting to $20.5 million.
- RedHill Biopharma's Assets Average fell 19.20% to $18.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $18.2 million, marking a year-over-year decrease of 19.20%. This contributed to the annual value of $20.5 million for FY2024, which is 77.41% down from last year.
- Latest data reveals that RedHill Biopharma reported Assets Average of $20.5 million as of FY2024, which was down 77.41% from $91.0 million recorded in FY2023.
- RedHill Biopharma's 5-year Assets Average high stood at $180.7 million for FY2021, and its period low was $20.5 million during FY2024.
- In the last 3 years, RedHill Biopharma's Assets Average had a median value of $91.0 million in 2023 and averaged $93.8 million.
- Per our database at Business Quant, RedHill Biopharma's Assets Average surged by 86.32% in 2020 and then slumped by 77.41% in 2024.
- RedHill Biopharma's Assets Average (Yearly) stood at $127.2 million in 2020, then spiked by 42.10% to $180.7 million in 2021, then decreased by 5.91% to $170.0 million in 2022, then tumbled by 46.50% to $91.0 million in 2023, then tumbled by 77.41% to $20.5 million in 2024.